Efficacy and safety of a novel 450 nm blue diode laser versus plasmakinetic electrocautery for the transurethral resection of non-muscle invasive bladder cancer: The protocol and result of a multicenter randomized controlled trial

Efficacy and safety of a novel 450 nm blue diode laser versus plasmakinetic electrocautery for the transurethral resection of non-muscle invasive bladder cancer: The protocol and result of a multicenter randomized controlled trial

ObjectivesTo be the first to apply a novel 450 nm blue diode laser in transurethral resection of bladder tumor (TURBt) to treat patients with non-muscle invasive bladder cancer (NMIBC) and evaluate its efficacy and safety during the preoperative period compared to the conventional plasmakinetic elec...

Full description

Bibliographic Details
Main Authors: Kaijie Wu, Dali Jiang, Lianhua Zhang, Shuai Jiang, Tianhai Lin, Yi Luo, Jinhai Fan, Tao Yang, Haige Chen, Peng Zhang, Xinghuan Wang, Qiang Wei, Jianming Guo, Yiran Huang, Dalin He
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Oncology
Subjects:
blue diode laser
plasmakinetic electrocautery
TURBt
NMIBC
RCT
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1065735/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1065735/full

Similar Items